Ginkgo Bioworks Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference
Ginkgo Bioworks Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference
Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Ginkgo Biosecurity is building and deploying the next-generation infrastructure and technologies that global leaders need to predict, detect, and respond to a wide variety of biological threats. For more information, visit ginkgobioworks.com and ginkgobiosecurity.com, read our blog, or follow us on social media channels such as X (@Ginkgo and @Ginkgo_Biosec), Instagram (@GinkgoBioworks), Threads (@GinkgoBioworks) or LinkedIn.BOSTON, Aug. 30, 2024 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that Chief Financial Officer, Mark Dmytruk, is scheduled to participate in a fireside chat at the Morgan Stanley 22nd Annual Global Healthcare Conference on Friday, September 6 at 11:30 a.m. ET.
2024年8月30日波士顿/美通社/ — 生物工程公司Ginkgo Bioworks Holdings, Inc. (纽交所: DNA)已经开始建立领先的电芯编程和生物安全平台。今天宣布首席财务官Mark Dmytruk将参加摩根士丹利全球第22届医疗保健年会的座谈会，时间为9月6日星期五上午11点30分Et。
Further details, a webcast link, and a replay of the fireside chat will be posted on the company's investor relations website at .
更多详细信息、网络直播链接以及座谈会的回放将发布在公司的投资者关系网站上。 .
About Ginkgo Bioworks
Ginkgo Bioworks 正在建立一个平台，使客户能够像编程计算机一样编程细胞。公司的平台正在实现在各个市场中应用生物技术，从食品和农业到工业化学品再到制药业。Ginkgo 还积极支持多项 COVID-19 应对举措，包括 K-12 商汤测试、疫苗制造优化和治疗发现等。有关更多信息，请访问:
Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Ginkgo Biosecurity is building and deploying the next-generation infrastructure and technologies that global leaders need to predict, detect, and respond to a wide variety of biological threats. For more information, visit ginkgobioworks.com and ginkgobiosecurity.com, read our blog, or follow us on social media channels such as X (@Ginkgo and @Ginkgo_Biosec), Instagram (@GinkgoBioworks), Threads (@GinkgoBioworks) or LinkedIn.
Ginkgo Bioworks是领先的电芯编程水平开放平台，提供灵活的端到端服务，为食品和农业、制药、制造行业和特种化学品等各种市场的组织解决挑战。Ginkgo Biosecurity正在构建和部署全球领导者需要预测、检测和应对各种生物威胁的下一代基础设施和技术。更多信息，请访问 ginkgobioworks.com和页面。ginkgobiosecurity.com阅读我们博客，或在社交媒体频道关注我们，如X（@Ginkgo），(@ConcentricByGBW)Ginkgo和银杏生物安全），Instagram（@GinkgoBioworks），Threads（@GinkgoBioworks）或GinkgoBioworks）GinkgoBioworks或LinkedIn.
Ginkgo Bioworks Contacts:
INVESTOR CONTACT:
投资者联系方式：
[email protected]
[email protected]
MEDIA CONTACT:
媒体联系人：
[email protected]
[email protected]
SOURCE Ginkgo Bioworks
源自Ginkgo Bioworks